AssetMark Inc’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $50.6K | Buy |
3,620
+435
| +14% | +$6.09K | ﹤0.01% | 1562 |
|
|
2025
Q1 | $43.3K | Sell |
3,185
-494
| -13% | -$6.72K | ﹤0.01% | 1476 |
|
|
2024
Q4 | $75K | Sell |
3,679
-129
| -3% | -$2.63K | ﹤0.01% | 1307 |
|
|
2024
Q3 | $111K | Buy |
3,808
+580
| +18% | +$16.9K | ﹤0.01% | 1133 |
|
|
2024
Q2 | $75K | Sell |
3,228
-86
| -3% | -$2K | ﹤0.01% | 1159 |
|
|
2024
Q1 | $68K | Sell |
3,314
-236
| -7% | -$4.84K | ﹤0.01% | 1111 |
|
|
2023
Q4 | $76.2K | Buy |
3,550
+1,402
| +65% | +$30.1K | ﹤0.01% | 1078 |
|
|
2023
Q3 | $44.3K | Buy |
2,148
+707
| +49% | +$14.6K | ﹤0.01% | 1118 |
|
|
2023
Q2 | $42.5K | Buy |
1,441
+669
| +87% | +$19.7K | ﹤0.01% | 1118 |
|
|
2023
Q1 | $17.8K | Buy |
772
+198
| +34% | +$4.56K | ﹤0.01% | 1200 |
|
|
2022
Q4 | $16K | Buy |
574
+136
| +31% | +$3.78K | ﹤0.01% | 1242 |
|
|
2022
Q3 | $13K | Buy |
+438
| New | +$13K | ﹤0.01% | 1196 |
|